The 131st Annual Meeting (November 15-19, 2003) of APHA

Abstract #70301

Jennifer Kates, Kaiser Family Foundation, 1330 G. St., NW, Washington, DC 20005, 202-347-5270, jkates@kff.org

AIDS Drug Assistance Programs (ADAPs) provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS in the 50 states, the District of Columbia, Puerto Rico, Guam, and the Virgin Islands. ADAPs, part of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, are not entitlement programs; annual federal, and in some cases state, appropriations determine how many clients ADAPs can serve and the level of services they can provide. Each state or territory administers its own ADAP, including the establishment of financial and clinical eligibility criteria and ADAP drug formularies. As a result, there is wide programmatic variation across states and in client access to ADAPs. This paper will provide a national perspective on these important programs, using data from the National ADAP Monitoring Project, an ongoing project of the Kaiser Family Foundation, the National Alliance of State and Territorial AIDS Directors, and the AIDS Treatment Data Network, which collects annual data on state ADAPs. It will include an analysis of recent and trend data on ADAP client utilization, drug expenditures, and budgets as well as an assessment of major program characteristics and components (e.g., program eligibility, formularies, drug purchasing arrangements, etc.). Reasons for these trends will be explored. A key focus of this paper will be a discussion of ADAP program variability across the country and the implications of this variation for client access.

Learning Objectives:

• An understanding of the important national trends in client utilization, drug expenditures, and key program components of state AIDS Drug Assistance Programs, including how these data vary across the United States.

Keywords: HIV/AIDS, Financing

Related Web page: www.kff.org/docs/sections/hivaids/adap.html

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: Kaiser Family Foundation, National Alliance of State and Territorial AIDS Directors, AIDS Treatment Data Network
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.